Navigation Links
Food Colour in Sausages, Burgers Could Trigger Cancer

Food specialists have warned that a dye, used sometimes to colour meat for sausages and burgers, could trigger cancer .

The European Food Safety Authority (EFSA) recently announced that it could no longer guarantee a safe daily limit for consumers to eat meat with the colourant, Red 2G, which is also known as E128.

EFSA released a statement describing Red 2G, as a "safety concern". A meeting has been called by the Food Standards Agency on July 10, to establish the extent of the use of the dye in Britain.

Many large brands have recently been trying to do away with additives and artificial colourings from their meat products. However, E128 is still frequently used, particularly in economy sausages and burgers.

Under current EU food laws, limited amounts of Red 2G are permitted for use only in certain types of breakfast sausages and burger meat.

The EFSA experts said Red 2G was converted in the body into a substance called aniline. Following tests on rats and mice, the researchers concluded that aniline should be considered as a carcinogen or cancer-causing.

"Based on similar metabolism of aniline in animals and humans, a carcinogenic risk for man cannot therefore be excluded," the Telegraph quoted a spokesman for the EFSA, as saying.

"Given new scientific evidence it cannot be excluded that aniline's carcinogenic potential is due to damage to the genetic material of the cells. It is therefore not possible to determine a level of intake for aniline which may be regarded as safe for humans," he added.

A spokesman for the FSA said that once the meeting is concluded, the agency will decide what action to take.

The EFSA is re-assessing the scientific evidence on all food colourings as part of a wider review of a range of food additives presently authorised for use in the EU.

A spokesman for the Food and Drink Federation, which represe
'"/>




Page: 1 2

Related medicine news :

1. Colour Identification Lies Wholly On the Left Hemisphere of the Brain.
2. Colour Of Urine Can Reveal The Health Status Of The Patients
3. Colourful vegetables lower asthma risk
4. Type 2 Diabetes Could Be Tackled Using Curry Colouring and Fat Mix
5. Red 2G Food Colour to Be Banned by EU Due to Cancer Fears
6. Researchers Reveal Why Eyes See Things Changing Colour
7. Lean Protein Could Be Key to Obesity Drugs
8. Nasal Spray Could Take Drugs Direct to Brain.
9. Nasal Spray Could Take Drugs Directly to Brain
10. Oxygen Usage During Exercise Could Indicate Heart Problems
11. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
Post Your Comments:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 1New Study of House Health Reform Bill 3A California Faces Over 243 7 Billion in Medicare Funded Nursing Home Cuts Over Ten Years 55196 2Testosterone Therapy May Help Men With Heart Failure 55194 1Testosterone Therapy May Help Men With Heart Failure 55194 2Testosterone Therapy May Help Men With Heart Failure 55194 3